HALO logo
halo search icon
Rigel Pharmaceuticals, Inc.

US$28.82

Price Change Indicator
0.52 (1.84%)
Rigel Pharmaceuticals, Inc.
RIGL · NAS

Rigel Pharmaceuticals, Inc.

Start Trading RIGL for Free

US$28.82

Price Arrow0.52 (1.84%)
20/05/2026 04:00:00 PM
All-CompaniesAll-ConsensusConsensus CheapEMA 125 BreakdownHALO AllHALO ValueHammer Bearish (Realtime)Recent Price upgrade
Consensus Score
Lock Icon/10
Recommend
Lock
Target Price
Lock
Deviation
Lock
Unlock Full Consensus Insights

Rigel Pharmaceuticals, Inc. Overview

RIGL Health Scores

Short Term

Mean Reversion

Neutral

Trend

Neutral

Event

Neutral

HALO Model

Mqv

Very Weak

Garp

Very Weak

Mqv Small

Neutral

Valuation

Value

Lock Icon

Consensus

Lock Icon

Momentum

Price

Weak

Earnings

Very Weak

Growth

Earnings

Very Weak

Dividends

Very Weak

Quality

Capital Efficiency

Very Weak

Balance Sheet

Very Weak

About RIGL

icon
icon

Telephone

1.650.624.1100

icon

Address

Suite 900, 611 Gateway Boulevard, South San Francisco, CA 94080-1985

Description

Rigel Pharmaceuticals, Inc. operates as a clinical stage biotechnology company. It discovers and develops novel, targeted drugs in the therapeutic areas of immunology, oncology and immune oncology. The firm focuses on intracellular signalling pathways and related targets that are critical to disease mechanisms. The company's products include Tavalisse, Fostamatinib and R835. Rigel Pharmaceuticals was founded by Donald G. Payan, James M. Gower, Thomas A. Raffin, Garry P. Nolan and Ronald B. Garren on June 14, 1996 and is headquartered in South San Francisco, CA.

RIGL Price Chart

Key Stats

Market Cap

US$523.61M

PE

2.20

EV/EBITDA

5.5

Dividends Overview

DIV Yield

0%

Franking

0%

Ex Dividend Date (est.)

N/A

Market Data

52 weeks range

Low 18.14 - 52.24

Trade Value (12mth)

US$4,094,917.00

1 week

-2.45%

1 month

-12.36%

YTD

-32.35%

1 year

35.15%

All time high

310.00

Key Fundamentals

EPS 3 yr Growth

-700.60%

EBITDA Margin

43.50%

Operating Cashflow

$76m

Free Cash Flow Return

32.20%

ROIC

156.20%

Interest Coverage

17.50

Quick Ratio

2.30

Other Data

Shares Outstanding (Fully Diluted)

20m

HALO Sector

Healthcare

Next Company Report Date

09-Mar-27

Next Ex Dividend Date

N/A

Next Dividend Pay Date

N/A

Reporting Currency

USD

Short Sell (% of issue)

0.00

RIGL Announcements

Latest Announcements

DateAnnouncements
21 May 26
21 May 26
13 May 26
13 May 26
06 May 26

RIGL Fundamentals

Per Share Records

Historical data

Forecast data

USD2021202220232024202320242025202620272028
Per Share, Growth & Valuations
EPS (Basic)
 $locklocklocklock-1.440.9920.4locklocklock
EPS (Fully Diluted)
 $locklocklocklock-1.440.9919.48locklocklock
Growth
 %locklocklocklock57.61691,951.6locklocklock
PE
 XlocklocklocklockN/A172.2locklocklock
EV/EBITDA
 XlocklocklocklockN/AN/A5.5locklocklock

Dividends

Key Stats

Ex Dividend Date (est.)

N/A

DIV Yield

0%

Franking Level

0%

DPSg

N/A

Quality Yield

lock

Falling Divs over next 2

lock

Want to learn more?Frequently asked questions.
What is the current share price of Rigel Pharmaceuticals, Inc. (RIGL:NAS)?
Halo FAQ
The current share price of Rigel Pharmaceuticals, Inc. (RIGL:NAS) is USD$28.82.
What is the 52-week high share price for Rigel Pharmaceuticals, Inc. (RIGL:NAS)?
Halo FAQ
The 52-week high share price for Rigel Pharmaceuticals, Inc. (RIGL:NAS) is USD$52.24.
What is the 52-week low share price for Rigel Pharmaceuticals, Inc. (RIGL:NAS)?
Halo FAQ
The 52-week low share price for Rigel Pharmaceuticals, Inc. (RIGL:NAS) is USD$18.14.
What is the dividend yield for Rigel Pharmaceuticals, Inc. (RIGL:NAS)?
Halo FAQ
Rigel Pharmaceuticals, Inc. (RIGL:NAS) does not pay a dividend.
What was Rigel Pharmaceuticals, Inc. (RIGL:NAS) last dividend payment?
Halo FAQ
Rigel Pharmaceuticals, Inc. (RIGL:NAS) does not pay a dividend.
What is the franking level for Rigel Pharmaceuticals, Inc. (RIGL:NAS)?
Halo FAQ
Rigel Pharmaceuticals, Inc. (RIGL:NAS) has a franking level of 0.00%.
In which sector is Rigel Pharmaceuticals, Inc. (RIGL:NAS) classified?
Halo FAQ
Rigel Pharmaceuticals, Inc. (RIGL:NAS) is classified in the Healthcare.
What is the price-to-earnings (P/E) ratio for Rigel Pharmaceuticals, Inc. (RIGL:NAS)?
Halo FAQ
The current P/E ratio for Rigel Pharmaceuticals, Inc. (RIGL:NAS) is 2.20.

See beyond the curve.

One solution for research, investing and portfolio management.
Start FREE Trial